United Lithium Expects Results From Hydroxide Testing Program Next Month

United Lithium (CSE: ULTH) continues to conduct lithium hydroxide testing. The firm this morning provided an update on the test program, indicating that it expects to have results from the program by the end of next month.

The testing currently being conducted is examining ways in which the company can optimize the production of lithium hydroxide. Optimizations include process cost reduction and increased efficiency, among other items. Different parameters surrounding temperature, residence time, pH, and concentrations of lithium are being utilized to determine the best operating ranges.

The research is being conducted by Dr Abdul Halim, whom to date has provided significant process improvements for the company. R&D successes to date have lead to higher lithium recovery rates for the production of lithium carbonate, improvements in lithium mineral concentrate production from feed materials, as well as improvements in the chemical roasting process.

“We are moving forward on multiple exploration and technology fronts simultaneously. […] We are looking where possible to reduce timelines and move each of our projects toward completion of all-important feasibility studies, so we can economically and sustainably realize the value of our projects and technologies,” commented Michael Dehn, CEO of United Lithium on the developments.

The company also indicated it is now holding discussions for the production of value-added products from the feldspar, quartza, and mica by-products that occur as part of the recovery of lithium pegmatites. Such value-added products would provide the benefit of reducing waste from a mining operations, making the operation more environmentally friendly.

United Lithium last traded at $0.52 on the CSE.


FULL DISCLOSURE: United Lithium is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover United Lithium on The Deep Dive, with The Deep Dive having full editorial control. Additionally, the author personally holds shares of the company. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Share
Tweet
Share